WorldStage– Damitop Consulting Ltd, a substantial shareholder in Neimeth International Pharmaceuticals Plc, has acquired 10 million ordinary shares in the pharmaceutical company.
According to an insider dealing notification published by the Nigerian Exchange Group (NGX) on September 10, 2026, the transaction was executed on June 3, 2026, in Lagos.
Related stories
Clinoscope Services expands holdings in Neimeth Pharmaceuticals with ₦312m share purchase
Neimeth, shareholders get March 31 date by court to meet on new share scheme
The shares were purchased at an average price of ₦11.00 per unit, bringing the total value of the transaction to ₦110 million. The notice was formally signed by Neimeth’s Company Secretary, Chinenye S. Adekanmbi.
Key Transaction Highlights
Insider / Purchaser: Damitop Consulting Ltd (Substantial Shareholder)
Issuer: Neimeth International Pharmaceuticals Plc (ISIN: NGNEIMETH001)
Volume Traded: 10,000,000 ordinary shares
Execution Price: ₦11.00 per share
Transaction Date: June 3, 2026
Notification Date: September 10, 2026
